Prices for:
 Do you expect more from a dermal filler?
For the past four years an increasing number of doctors have experienced the benefits of using the German Biopolymer produced Matridur, MatriGel & Matridex cross linked hyaluronic acid fillers.
Amongst the benefits appreciated by both doctor and client is the ease with which the material is expelled from the 30 gauge needle and the quality and duration of the correction.
Two additional products have now been added to the range – Matridex DX and Matrisoft. Matridex DX , administered subcutaneously gives a volumising result that lasts 12 to 18 months. Matrisoft – non cross-linked HA (14mg per ml) is for skin rejuvenation and revitalization, injected into the papillary dermis.
| MATRIDUR 1.0ml |
$170 |
| MATRIGEL 1.0ml |
$175 |
| MATRIDEX 1.0ml |
$208 |
| MATRIDEX DX 1.0ml |
$221 |
| MATRISOFT 1.0ml |
$98 |
For orders of 20 or more a discount of 10% may be taken For orders of 50 or more a discount of 20% may be taken. Shipping is on day of order unless advised otherwise.
Matridex ® DX
Injectable filler for tissue augmentation
Matridex DX is a sterile suspension of positively charged dextranomere microspheres (DEAE Sephadex) in a hydrogel consisting of Cross-linked hyaluronic acid sodium salt (Hylan Gel)
DEAE Serphadex/positively charged Dextranomere
Matridex DX is indicated for the intracutaneous and subcutaneous injection for sculpting and forming the body and the face.
The use is only permitted by medical personal.
Two sterile needles for the injection and two labels with the number of the lot and the expiry date are accompanied to the product.
One label is for the patients-card to guarantee the tracebility of the product.
1 ml Matridex® DX contains:
Cross-linked hyaluronic acid 17 mg
Dextranomere 50 mg
Sodium chlorid 6,9 mg
Water for injection ad 1 ml
Final sterilization in moist heat.
Matridex DX is indicated for the temporary volume substitution via subcutaneous injection. The duration time in the tissue is approximately 12-18 months.
Matridex DX may not be administered in case of:
Tendencies to hypertrophic and cheloidal scars, auto-immune disorders, under immunotherapy, in case of infective and diseased skin parties, coagulation defects, anti-coagulating therapy, during pregnancy, for young children and teenagers under 18 years. Also in case of sensitivity to hyaluronic acid and Dextranomeres.
Matridex DX is not suitable for the implantation in bone material, ligaments, tendons or muscles .
Do not inject into blood vessels.This can cause embolism.
Only inject subcutaneously.
Before injecting, the treatment area has to be covered with a topical anaesthesia product to avoid pain during the time of implantation.
Possible side effect, caused by the topical anaesthesia can be: local reaction on the skin like redness, paleness. This reaction are transistent. For that reason, the user has to read carefully the instructions for use of the anaesthesia.
As with all injectable fillers, the following side-effects can appear:
Reddening (erythema), swelling (oedema), pain and haematoma. These symptoms disappear spontaneously after 2-4 days without any medicinal treatment whatsoever.
When injecting Matridex DX, there may be injection pain and a discolouration at the point of injection. The area around the injection regularly bleeds minimally, which mostly ceases spontaneously. In some cases there may be stronger bleeding, especially in the case of disturbed blood clotting, which can present itself as a haematoma.
Through the injection, there is the possibility of local infection, injection abscesses, injuries to nerves and blood vessels with bleeding under the skin, as well as tissue necrosis in vessel-dependant parties.
The measures to be taken against undesired side-effects ( redness, swelling, pain, oedema ) resulting from augmentation of Matridex DX are dependent firstly on the side-effects themselves or the restrictions imposed on the patient.
Before beginning the treatment, the patient must be informed and understand the effects and possible side-effects involved. The patient information must be given to the patient.
Before injecting, the treatment area must be thoroughly disinfected.
Matridex DX is injected intracutaneous or subcutaneously with the mounted needle.
Do not inject into blood vessels, i.e. aspirate before injecting. Inject slowly.
Do not use more than 5 ml in one treated region.
Before use, check the intactness of the sterility protection ( blister).
If the sterile protection is damaged, don't use the product.
Store between 18° to 25° C.
Expiry date see on the bottom of the box and the labels.
After the expiry date do not use Matridex DX.
Store out of the reach of children.
Note: the graduations on the syringe are only there as orientation for the user related to the end volume. They have no measuring function. They demonstrate only the amount used related to the standard volume of 1 ml.
The amount of injected material can be controlled visually and by touch.
BioPolymer GmbH & Co. KG
Bahnhofsplatz 4
56410 Montabaur
CE marking according to MDD 93/42/CEE
0297 is the number of the notified body
Date of information: January 2006
|